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Background/Aims
The prevalence of irritable bowel syndrome (IBS) varies from 4% to 20% in different Asian nations. Prevalence of IBS in native 
North Indian community is not known.
Methods
Between November 2008 to December 2009, we estimated the prevalence of IBS in a rural community of Ballabgarh block, 
located in Haryana state. A structured questionnaire based on Rome III module was used to collect symptoms related to IBS 
from all the participants in a door to door survey. A Rome III criterion was used for diagnosis of IBS. IBS was further classified 
based on predominance of symptoms as constipation predominant, diarrhea predominant, mixed and unspecified based on 
Rome III module.
Results
There were 4,767 participants (mean age 34.6 ± 10.8, males 50%). Overall, 555 (11.6%; 95% CI, 10.7-12.5) had constipation, 
542 (11.4%; 95% CI, 10.5-12.3) diarrhea and 823 (17.3%; 95% CI, 16.2-18.4) abdominal pain. The overall prevalence of IBS was 
4% (95% CI, 3.5-4.6). The prevalence of constipation predominant IBS was 0.3% (95% CI, 0.16-0.49), diarrhea predominant IBS 
1.5% (95% CI, 1.18-1.90), mixed IBS 1.7% (95% CI, 1.35-2.11) and unsubtyped IBS 0.5% (95% CI, 0.32-0.75). The prevalence 
of IBS was significantly higher in females compared with males (4.8% vs 3.2%, P = 0.008). However, there was no significant 
difference between males and females in the prevalence of different subtypes of IBS. The prevalence increased with age.
Conclusions
The prevalence of IBS in a North Indian community is 4%. IBS poses a significant burden on the rural adults.
(J Neurogastroenterol Motil 2011;17:82-87)
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Introduction
The magnitude of patients with functional gastrointestinal 
disorders visiting outpatient clinics is high and accounts for up to 
one third of outpatient consultations.
1 Irritable bowel syndrome 
(IBS) is a functional gastrointestinal disorder characterized by 
abdominal pain, discomfort and alteration of bowel habits in the 
absence of any organic disorder. The prevalence of IBS in the 
general population varies from 9% to 22% in the United States 
and European countries.
2-6 The rapid socioeconomic development 
in the last 20 years has also created a transition in the health and 
environmental situation in Asia. The prevalence of IBS among 
Asian communities appears to be on the rise.
7,8 
Using Rome II criteria, the prevalence of IBS in Singapore 
(8.6%) and Japan (9.8%) are comparable to that in Australia 
(6.9%) and Europe (9.6%), although not as high as in Canada 
and the UK (12%).
9-13 The prevalence of IBS both in the com-
munity and even in the outpatient clinics varies and depends on 
the criteria used such as Manning criteria or Rome criteria.
5,14
Recently, the Indian Society of Gastroenterology conducted a 
study involving close to 3,000 IBS patients and 4,500 community 
subjects drawn from 18 centers.
15 This study was unique in that 
the authors had adopted an entirely symptoms based diagnosis of 
IBS rather than using any of the Rome criteria or Manning cri-
teria. The estimated prevalence of IBS in this study was 4.2%. In 
another study including 2,549 subjects from an urban commun-
ity from Western part of India (Mumbai), Shah et al
16 reported 
the prevalence of IBS to be around 7.5% by Manning criteria. 
Both of the above studies were not really a community based 
study. While the first study included a mix of patients relatives, 
hospital staff, students and general population; the second study 
included relatives of patients visiting hospitals, students and staff 
members of the hospital.
15,16 There is a lack of data on the real 
and native community study from India. We therefore planned to 
estimate the prevalence of IBS using Rome III criteria in a rural 
North Indian community. 
Materials and Methods
Study Setting
The study was conducted in the rural field practice areas of 
the Centre for Community Medicine, All India Institute of Me-
dical Sciences between October 2008 and December 2009. The 
rural practice area consisted of 87,002 population spread over 28 
villages in Ballabgarh block of Faridabad district and is served by 
2 primary health centers and a sub-district level hospital at Bal-
labgarh. This community is a native stable community and mi-
gration rate in this community is minimal negligible. 
Sample Size Calculation
The study was conducted as an add-on on a previous study 
carried out to elicit the prevalence of celiac disease. A total of 
4,767 adults were included in the study and all of them were sub-
jected to questions on IBS. Community studies in India have 
shown the prevalence of IBS to be approximately 5% and assum-
ing this to be the expected prevalence, this sample size was ex-
pected to give a relative precision of 33% ie, from 3.4%-6.6% at 
5% alpha error. On using a proportionate to population size sam-
pling list, 12 villages were selected for survey. These included 
Macchgarh, Sotai, Shahpur Kalan, Jawa, Panehra Kalan, Fateh-
pur, Chandawali, Chhainsa, Dayalpur, Mauzpur, Atali, Dayal-
pur and Khera.
Selection of Households and Individuals 
In the chosen villages, alternate households were selected for 
inclusion in the study. It was decided apriori that from each se-
lected household, 1 adult of either gender (defined as individual 
aged 18 to 64 years) would be included in the study. To aid se-
lection of the gender of adult to be interviewed from a household, 
each team was provided with a pre-randomized list. To select 1 
adult of the gender out of all adults of the same gender in a house-
hold, the names of all adult members of the selected gender in the 
household were listed. Then 1 member was selected by roll of a 
dice. The selected individual’s consent was taken and an ID num-
ber was assigned. 
Questionnaire Based on Rome III Criteria
A simple 10 point objective questionnaire based on Rome III 
IBS module was used in this study. The English version of the 
questionnaire was translated into the native language Hindi. 
Data Collection
The field investigators were trained to administer the pre-de-
signed questionnaire. The field investigators were provided with 
structured survey sheets which they used on listed and enrolled 
households as they went along with the survey. Any refusals or, 
locked households were also recorded in the sheet. After self-in-
troduction and informing the purpose of their visit, the field in-Govind K Makharia, et al
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Table 1. Demographic Details of Irritable Bowel Syndrome Pa-
tients
Parameter
Number of
participants
screened
Number of
patients
with IBS
Prevalence of IBS
(95% CI)
Total number 4,767 191 4.0% (3.5-4.6)
Age stratification
    18-30
    31-40
    41-50
    51-60
1,993 (41.8%)
1,506 (31.6%)
   821 (17.2%)
   447 (9.4%)
  63
  60
  42
  26
3.2% (2.5-4.1)
4.0% (3.1-5.1)
5.1% (3.7-6.9)
5.8% (3.8-8.4)
P = 0.001
a
Gender
    Male
    Female
2,383
2,384
  77
114
3.2% (2.5-4.0)
4.8% (4.0-5.7)
P = 0.008
IBS, irritable bowel syndrome.
aChi-square for trend.
vestigators sought consent from the respondents for participating 
in the study.
Quality Control
During the study, supervisory visits and random checks were 
done regarding the screening of the subjects. Every 4-6 weeks, 
review meetings were conducted by study personnel and data 
were reviewed.
Criteria for the Diagnosis of Irritable Bowel 
System
IBS was diagnosed on the basis of Rome III criteria, accord-
ing to which, recurrent abdominal pain or discomfort at least 3 
days per month in the last 3 months with onset of symptoms at 
least 6 months back was essential for suspecting IBS. In addition, 
to diagnose a person as IBS, the pain needed to be associated with 
at least 2 out of 3 features which included improvement of pain or 
discomfort with defecation and onset of pain or discomfort asso-
ciated with a change in frequency or form (appearance) of stool.
The patients who were diagnosed as having IBS were further 
subclassified into diarrhea predominant IBS (IBS-D) if they had 
loose, mushy or water stools in the last 3 months with no hard or 
lumpy stools; constipation predominant IBS (IBS-C) if they had 
hard or lumpy stools with no loose, watery mushy or watery stools 
in the past 3 months; mixed IBS (IBS-M) if they had both loose 
and hard stools in the past 3 months; and unsubtyped IBS (IBS- 
U) if they did not report either loose or hard stools in the past 3 
months.
Statistical Methods 
All the filled questionnaire sheets were entered in computer 
using Epi info Version 3.4.1 (CDC’s database and statistics soft-
ware for public health professionals, Atlanta, GA, USA). Double 
data entry was done for quality control. Entered data were ana-
lyzed to assess the characteristics of the study population includ-
ing age and gender distribution. STATA 9.1 statistical software 
was used for data analysis. Proportions and 95% CI were calcu-
lated using Chi-square test. A P-value less than 0.05 was consid-
ered significant.
Results
In this prospective study to find out the prevalence of IBS in 
a rural community, 4,767 subjects were interviewed. The mean 
age of the participants was 34.6 ± 10.8 years and 2,383 (50%) 
were male. The age distribution is shown in Table 1.
Subjects Having Symptoms of Diarrhea, Con-
stipation or Abdominal Pain
Of 4,767 subjects interviewed, 555 (11.6%; 95% CI, 10.7- 
12.5) had constipation, 542 (11.4%; 95% CI, 10.5-12.3) had di-
arrhea and 823 (17.3%; 95% CI, 16.2-18.4) had abdominal pain. 
Prevalence of Irritable Bowel Syndrome
One hundred and ninety-one subjects fulfilled the Rome III 
criteria for diagnosis of IBS. Therefore, the overall prevalence of 
IBS was 4% (95% CI, 3.5-4.6). 
Prevalence of Subtypes of Irritable Bowel Syn-
drome
These 191 patients were further subclassified into IBS-D, 
IBS-C, IBS-M and IBS-U according to the Rome III. The rela-
tive proportion of IBS-M was 42.4%, IBS-D 37.7%, IBS-U 
13.6% and IBS-C 6.3%. The prevalence of IBS-C was 0.3% 
(95% CI, 0.16-0.49), IBS-D 1.5% (95% CI, 1.18-1.90), IBS-M 
1.7% (95% CI, 1.35-2.11) and IBS-U 0.5% (95% CI, 0.32- 
0.75). 
Age and Gender Stratified Prevalence of Ir-
ritable Bowel Syndrome and Its Subtypes
The prevalence of IBS increased as the age advanced and was 
maximum (5.8%) in the age group 51-60 (Table 1 and Fig. 1). Prevalence of IBS in India
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Table 2. Gender Distribution and Prevalence of Subtypes of Ir-
ritable Bowel Syndrome
Total
Men
(n = 2,383)
Women
(n = 2,384)
IBS (total) 191 77 (3.2%) 114 (4.8%)
IBS-C (constipation predominant)   12   4 (0.2%)     8 (0.3%)
IBS-D (diarrhea predominant)   72 30 (1.3%)   42 (1.8%)
IBS-M (mixed type)   81 34 (1.4%)   47 (2.0%)
IBS-U (unsubtyped)   26   9 (0.4%)   17 (0.7%)
IBS, irritable bowel syndrome.
Figure 1. Prevalence of irritable bowel syndrome subtypes in different
age group. IBS, irritable bowel syndrome; IBS-C, constipation pre-
dominant IBS; IBS-D, diarrhea predominant IBS; IBS-M, mixed IBS;
IBS-U, unsubtyped IBS.
Figure 2. Prevalence of irritable bowel syndrome subtypes in men and
women. Abbreviations as Figure 1.
The prevalence of IBS was significantly higher in females com-
pared with males (4.8% vs 3.2%, P = 0.008) (Table 2). However, 
there was no significant difference between males and females in 
the prevalence of different subtypes of IBS (Fig. 2). The preva-
lence of IBS-C, IBS-D, IBS-M and IBS-U in different age 
groups is shown in Figure 1. The prevalence of IBS-U in the age 
group 51-60 was highest among other age groups (P = 0.01).
Discussion
The prevalence of IBS was found to be 4% in the present 
Northern Indian rural community with the Rome III criteria. 
Two other studies on the prevalence of IBS in India were re-
ported. While Shah et al
16 reported a prevalence of 7.6% from 
Mumbai using Manning criteria; Ghoshal et al
15 reported a pre-
valence of 4.2% in their prospective multi-center study using 
clinical criteria. Unlike previous studies, the present study was 
done in a native Indian rural community which represents 72.2% 
of Indian population. This study was done as door to door survey 
using random sampling. The prevalence of IBS in both the above 
community based study was not only much lower than that re-
ported from the Western countries; but also much lower than 
community based studies from other Asian countries like Taiwan 
(22.1% by Rome II criteria),
17 China (11.5% by Manning cri-
teria),
18 Singapore (8.6% by Rome II criteria),
9 Malaysia (15.6% 
by Rome II criteria),
19 Bangladesh (8.5% by Rome II criteria),
20 
Pakistan (14% by Rome II criteria),
21 Turkey (10.2% by Rome 
II criteria),
22 Korea (6.6% by Rome II criteria)
23 and Japan (9.8% 
by Rome II criteria).
10
It is difficult to estimate the true prevalence of IBS as it is 
known to change depending on the criteria used for diagnos-
is.
11,14,24 Revisions of the diagnostic criteria for IBS have led to 
varying prevalence estimates in the same population. The Rome 
III criteria is less restrictive and requires a lower symptom fre-
quency than Rome II criteria for IBS. Similarly, the prevalence of 
IBS has been reported to be higher with Manning criteria and 
Rome I criteria compared with Rome II criteria.
14 In a study in-
cluding 2,000 individuals from Spain, Mearin et al
14 reported a 
much lower prevalence rate using the Rome II criteria (3.3%) 
than that obtained using the Manning (10.3%) and the Rome I 
criteria (12.1%). In another study, where a representative sample 
of 1,000 adults were assessed for prevalence of IBS using Rome 
II and Rome III integrative questionnaire; the prevalence for 
IBS was found to be 2.9% with Rome II criteria and 11.4% with 
Rome III criteria.
25 Xiong et al
18 from Southern part of China re-
ported a prevalence of IBS as 11.5% with Manning criteria and 
5.6% with Rome II criteria in a population based study including 
4,178 subjects. More recently, a good agreement in the preva-
lence of IBS was reported by Park et al
24 from Korea using Rome Govind K Makharia, et al
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II (8%) and Rome III criteria (9%). There is a criticism that 
Rome II and Rome III criteria are not suitable for Asian nations 
because both of them underestimate the prevalence of IBS as 
aptly shown in the study from Tehran.
26,27 In a study including 
18,180 participants from Tehran Province, Iran, while the preva-
lence of functional bowel disease was 10.1%, the prevalence of 
IBS was only 1.1% using Rome III criteria against the expected 
higher prevalence rates for IBS.
27 Our estimation of prevalence of 
4% may be an underestimation of prevalence of IBS.
In this prospective rural community based study, IBS-M 
with alternating features of diarrhea and constipation was the 
most common form of IBS in India with prevalence of 1.7% 
closely followed by IBS-D with prevalence of 1.5%. Predomi-
nance of IBS-M among IBS patients has also been reported from 
the United State.
3 In the present study, the prevalence of con-
stipation predominant IBS was 0.3% and this may be due to a 
higher fiber intake and faster gut transit time among Indians.
28
The prevalence of IBS in the present study was higher in fe-
males compared to males. While IBS is more common in women 
than men in many Western countries; no consistent differences 
however has been observed from Asia.
2,3,12 While studies from 
many Asian nations such as Hong Kong, Taiwan and Singapore 
have not revealed a gender difference in the prevalence of IBS, a 
female predominance has been reported from Bangladesh, Viet-
nam, Malaysia and Japan.
17,19,20,29-34 In the 2 previous hospital 
based studies from India, IBS was reported to be more common 
in males.
15,16 On the other hand, the prevalence of IBS between 
female and male was almost same in those who had symptoms of 
IBS in the community study from India with non health seek-
ers.
15 Since India is a male dominant society, health seeking be-
haviour of males is probably the best explanation for difference in 
the prevalence of IBS in the studies conducted in hospital setting 
and those done in the community.
13,35-38
Female sex hormones affecting gastrointestinal motility and 
differences in the serotonin synthesis in brain are proposed mech-
anisms for higher occurrence of motility disorders in women.
39,40
Considering the current prevalence of IBS in our commun-
ity, IBS still remains an under-diagnosed gastrointestinal disord-
er. This could be either due to low health seeking behavior of the 
community or, due to poor ability of medical fraternity in primary 
health care to diagnose the condition. There is no study available 
which correlates the severity of illness with health care seeking 
pattern of these patients. Further studies are therefore needed to 
study the health care seeking pattern of IBS patients in our pop-
ulation and to assess the severity of IBS. Also, there is no popula-
tion based investigation on the impact of IBS on the health-relat-
ed quality of life (HRQOL) in India. Assessment of HRQOL 
in these patients will not only give an insight on severity of disease 
but also help in optimizing the treatment of IBS.
The strength of this study is that it is a community based 
study with large sample size. This study is limited to native rural 
population and has not included urban population. There may be 
a difference in the prevalence of IBS amongst rural and urban 
population.
In conclusion, the prevalence of IBS in a Northern Indian 
community is 4%. The predominant subtype of IBS in this com-
munity is IBS-M.
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